Challenges in Tissue Engineering and Regenerative Medicine Product Commercialization: Building an Industry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges in Tissue Engineering and Regenerative Medicine Product Commercialization: Building an Industry

Published:2011-01 Issue:1-2 Volume:17 Page:1-3
ISSN:1937-3341
Container-title:Tissue Engineering Part A
language:en
Short-container-title:Tissue Engineering Part A

Author:

Hellman Kiki B.¹²,Johnson Peter C.³⁴,Bertram Timothy A.⁵,Tawil Bill⁶⁷

Affiliation:

1. President and CEO, The Hellman Group, LLC, Clarksburg, Maryland.

2. Chairperson of the TERMIS-NA Industry Committee.

3. Vice President, Research and Development, Avery Dennison Medical Products Division, Raleigh, North Carolina.

4. President and CEO, Scintellix, LLC, Raleigh, North Carolina.

5. Vice President, Science and Technology, Tengion, Inc., Winston-Salem, North Carolina.

6. Director, Global Expansion, Baxter Biosurgery, Westlake Village, California.

7. Adjunct Professor, Department of Bioengineering, University of California at Los Angeles, Los Angeles, California.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biomaterials,Biochemistry,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tea.2010.0436

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discussing the final size and shape of the reconstructed tissues in tissue engineering;Journal of Artificial Organs;2022-09-20

2. The Extracellular Matrix, Growth Factors and Morphogens in Biomaterial Design and Tissue Engineering;Extracellular Matrix for Tissue Engineering and Biomaterials;2018

3. How Regenerative Medicine Stakeholders Adapt to Ever-Changing Technology and Regulatory Challenges? Snapshots from the World TERMIS Industry Symposium (September 10, 2015, Boston);Tissue Engineering Part B: Reviews;2017-04

4. The Triple Helix model and the competence set: human spare parts industry under scrutiny;Triple Helix;2016-07-25

5. Enhancing Tissue Engineering and Regenerative Medicine Product Commercialization: The Role of Science in Regulatory Decision-Making for the TE/RM Product Development;Tissue Engineering Part A;2015-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3